Immuneering Corporation
Curated by SignalProvider of an AI-enabled bioinformatics platform for clinical solutions
Overview
Provider of an AI-enabled bioinformatics platform for clinical solutions. The company provides advanced data analysis services using state-of-the-art technologies including proprietary algorithms. Some of the datasets it uses to analyze are gene expression (microarray), single-nucleotide polymorphism (SNP), proteomic, clinical metadata, and next-generation sequencing (NGS) including RNAseq, exome sequencing, and whole-genome sequencing. Using these data sets captures difficult-to-find signals, generates biological hypotheses, and designs follow-up studies, contributing to the development of medicines for patients with cancer, autoimmune disease, neurodegeneration, and other serious diseases.
Key facts
- Founded
- 2019
- Headquarters
- Cambridge, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view